This is not about low quality drugs.. if TauRx goes through the rigour and transparency of their clinical trials and subsequent regulatory approval. The point you highlighted above pertains to a different issue: the presence of counterfeit drugs.

This is called comparing apples to apples.

Thus, the credibility of TauRx’s claims hinges on the rigour and transparency of their clinical trials and the subsequent regulatory approval. Without these, comparing their drugs to high quality, rigorously tested pharmaceuticals like the Pfizer COVID-19 vaccine would indeed be misleading.. 😀

Anak dari pondok sekolah, can I say:

Using Michael Porter’s Five Forces framework, if TauRx’s drugs were not thoroughly tested or failed to meet regulatory standards, they would not be classified as high quality pharmaceuticals. Instead, they would fall into the category of low quality alternatives, with all the associated risks and market implications.

I hope TauRx turns out well and that all investors here huat big big with their investments. Cheers!

I’ve been very active in the forum recently, so now it’s time for me to step back and maintain a lower profile as well.

ATK, I get your point. I wasn't trying to overanalyze or question your holdings. It's good to be confident in your decisions, and keeping a low profile can avoid unnecessary issues.

I usually only read detailed posts if they interest me or if I'm actively chatting here. Thanks for sharing your thoughts. 😀

Ok. 明白。 Thank you.

ATK, don't forget..we rely on your guidance to trade TauRx news.

Great. Let's focus on the long term potential of TauRx and adopt a long term investment approach. 😀

ATK, following validation, the MHRA aims to complete the detailed assessment within 150 days. So we should know the outcome by Dec 2024, right?

I received Singapore PR around the age of 25 and was later informed by the government that I was exempted from NS. ATK, 放过我 lei.. Please don't ask further questions.

云頂表現不錯啦..

我国去年吸引1600亿美元外资 全球排第三
https://www.zaobao.com.sg/finance/singapore/story20240730-4399779

新加坡去年吸引了1600亿美元（约2150亿新元）的直接外来投资，比2022年增长了13%。除了少数几只股票外，整体股市依然低迷。

Jeremy Siegel has predicted that the stock market is about to see a major shift once the Fed cuts rates. He believes that value stocks, which have underperformed compared to growth stocks this year, could start outperforming once the Fed eases its policy. Siegel also mentioned that cooling inflation data supports the likelihood of a Fed rate cut by September.

Identified growth and value stocks:

1) Nvidia: Growth stock
2) Wynn Resorts: Value stock
3) Las Vegas Sands: Value stock
4) Genting Berhad: Value stock
5) Genting Malaysia: Value stock
6) YTL Power: Growth stock
7) YTL: Growth stock

Stocks are approaching a 'watershed' moment as rate cuts unlock opportunity in unloved areas of the market, Wharton professor Jeremy Siegel says

Jul 29, 2024, 10:30 PM GMT+8


The stock market is about to see a major shift once the Fed cuts rates, Jeremy Siegel said.

The top economist thinks value stocks could start outperforming growth stocks once the Fed eases policy.

Cooling inflation data supports a Fed rate cut by September, Siegel predicted.


Stocks are about to reverse a long-running trend as rate cuts unlock an unsung area of the market, according to top economist Jeremy Siegel.

The Wharton School finance professor pointed to opportunity lurking in value stocks, an unloved group of the market that's underperformed this year when compared to growth stocks.

The S&P 500 Value index has climbed just 8% so far this year, according to S&P Global data. Those are far more muted returns than those seen in the S&P 500 Growth index, which has soared 20% from levels in January.

Growth stocks have outperformed partly due to Wall Street's AI craze, which has ignited investor fervor for growth stocks, like mega-cap tech firms.

But doubts are scaling over whether generative artificial intelligence is as revolutionary as investors originally priced in, Siegel said.

Meanwhile, the Fed looks poised to soon issue its first rate cut, which could unlock more movement on the market's value side, he predicted.

"You're not going to get value moving until the Fed drops rates, and more and more, when you see that rate drops are in the cards for the Fed, I think that narrative could very well continue," Siegel said in an interview with CNBC on Friday. "This really could be a watershed in terms of a trend we've seen for many many months, if not many years, of growth beating value."

Recent inflation data also makes the case for a soon-to-come Fed cut, Siegel said. The personal consumption expenditures price index, which is the Fed's preferred measure of inflation, continued to cool last month, fueling more hope that central bankers will soon ease up on monetary policy.

"Forward-looking, I think inflation looks very, very good," Siegel said, adding that an unexpectedly hot price reading wouldn't change the downward path of rates this year. "I don't think it changes the narrative of it at all that J. Powell is going to tee up a rate cut for the September meeting," he added.

Fed officials are set to convene this Tuesday and Wednesday to discuss their next policy move. Markets are pricing in a 96% chance the Fed will keep rates level on Wednesday but a 100% chance central bankers will cut rates at least 25 basis points by September, according to the CME FedWatch tool.

1 SGD = 3.43 MYR
1 USD = 4.61 MYR

记的人生有两个境界：
一个是知道，
一个是知足。
知道让人活得明白，
知足让人活得安然。

云顶这几天门前人落车马稀，今天会不会龙抬头？大家拭目以待。Go go.. GenB!

Nice song! ATK preparing to huat big big? 😀

Ohh! It should read: 新战国 4.87 - 4.65 - 5.10?? This is to depict the price has hit the lower support level at 4.65, and it's going to move up.

ATK must be hinting something very positive.

ATK, will there be a gap up tomorrow? We need your mentoring to trade TauRx news.

ATK, it's your approach... we may not understand. You may consider yourself a mentor, guiding all the mentees, or perhaps sharing your experience could be a better approach? 😀

😀

ATK, sharing your trading skills may not be welcome.., but everyone is eagerly awaiting updates on TauRx news

Validation is the first step in the regulatory review process.. 看来ATK信心将大增

Accepted the initial application ..sahaja. Still long way to go

We are mostly long-term investors, so you are like 对牛弹琴 here as we have no interest in it.

If you believe trading is so risky and only a small percentage can succeed, why not focus on the risks and proper strategies instead of promoting trading?

Do you think it's responsible to encourage stock trading in a forum where many may not have the necessary experience or knowledge to succeed?

Posted by AngTayKor > 2024-04-16 10:03 | Report Abuse

Posted by Michael_chan2022 > 2 days ago | Report Abuse
此时(4.60 - 4.70) 已经是国時代了...好比4.00- 4.10的時候
-----------

So new era at 4.48 now is equivalent to 3.88 during the previous old days? Hard to comprehend these strange measuring yardsticks.

****************
Posted by Michaelchan2024 > 3 days ago | Report Abuse
旧'战国':
1) 4.20 - 4.00 - 5.00
2) 4.65 - 4.45 - 4.95
3) 4.95 - 4.55 - 4.87
新战国 4.87 - 4.65? - 5.10
GenB 又進入新一波战国時期... 快要两年了回味无穷!
--------------


4.65 is an obvious support zone since 13/05/2024 la (support tested a few times recently). You can predict price will move to 5.10 next? You got the crystal ball? Long term investor keep analysing and predicting future price movements. I think @Dragon328 long term investment FA skills much more practical. I love to read his posts.

‐------------------


I've already stated that I'm a long term investor, so I don't care where the share price moves in the short term... even if it goes to the 'moon'. What matters to me is identifying the bottom to add more shares. Traders often create fear at the lower support levels, and I'm trying to understand if these really are the support levels.

Got to go, will be back in the evening.

It is trader who 看不起 long term investors.

As trader, you dont worry abt stock prices as you only react to price action. Hence, if price at 5.20, 5.00, 4.80 or 4.50, 4.30, 4.00 it's not an issue. We try to keep emotions out and execute trades like a mechanical robot
(Copy and paste)
with a significant emphasis on observing trends and price action.

On the other hand, many of us are long term investor. For us, price action is just part of the investment journey and not a primary concern. We focus on the general market trend, which is the overall direction in which the market or the price of an asset is moving over a specific period. While you may not prioritize identifying market trends and consider them to be rubbish posts, for us, they are crucial.

we come from two different 'worlds'. We are bound to have different opinions about everything from our investment strategies to how we see things:

You claim you're fully invested in TauRx, while we are Genting investors.

Truly the best! Appreciated.

No quack doctors and TauRx bashers here, we are Genting's investors. We also want the best outcome from TauRx as well.

What is meant to come will eventually come, bonus only for us..

Based on the behavioral assessment, ATK is likely a TauRx shareholder. His behavior suggests a mix of insecurity and a strong need for approval and validation from others, which might stem from a lack of confidence in his own decisions.

Thanks, anak dari pondok sekolah.

ATK, if you're so capable, talented, and successful, why are you so lacking in confidence? Why do you need to tell everyone you're a TauRx shareholder? Why are you so concerned about how others perceive you regarding your TauRx shares? Regardless of what they think, it's your investment strategy and decisions that matter most.

BTW, ATK, 說來話長, I am exempted from NS. Let's hope everything 開花結果 and soon it will be harvest time. Cheers!

No worry, I am at the Safra gym, going for dinner now. 😀

Unless you are Not a TauRx share owner.

As I said, stop worrying about Genting. In fact, you should spend more time monitoring the progress and development of TauRx and conduct a risk assessment of TauRx to understand how the risks can be addressed

This is not like you, ATK

As an experienced and observant trader for years, you must be well aware of the risks involved with TauRx. It seems surprising that someone with your background would ignore these factors. In fact, it raises doubts about whether you actually own TauRx shares. 😀

多加一句, 記住: 这裏高手如云, 卧虎藏龙... 那些真正有才智的人不需要炫耀，行事低调，对吧?

I hope you are having a great Sunday afternoon!

It's important to keep learning and improving, mastering risk mitigation skills to navigate and manage volatility. Enjoy your learning journey

I understand your optimism about the orally taken drug and its potential. However, considering that TauRx is not a listed company and shares are traded in the 'black' market, the risks are significant. Unlike Genting Berhad, where buying and selling shares is straightforward, the lack of confidence in TauRx's efficacy could lead to a sharp decline in share price. Once the market loses interest and confidence, it might be challenging to find buyers, and recovering your capital could be very difficult. So, while the market does reward the brave, it's crucial to be mindful of these risks..

Absolutely, both trading and investment can be risky and potentially very rewarding. This applies to your long term investment in TauRx. You mentioned going all-in on TauRx, believing it can give you much higher returns than stock trading. As the doctor pointed out, there are risks, and while the TauRx share price is unlikely to go to zero, it may experience a significant drop. It's important to keep learning and improving.. enjoy your learning journey.

Stop worrying about us. We are long term investors, and price action is not a concern for us. It's part and parcel of the investment journey.